Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.52B | 9.37B | 9.10B | 8.87B | 8.66B |
| Total Other Revenue | 107.00M | 102.00M | 99.00M | 96.00M | 94.00M |
| Total Revenue | 9.63B | 9.47B | 9.20B | 8.97B | 8.76B |
| Cost of Revenue | 2.78B | 2.76B | 2.69B | 2.62B | 2.56B |
| Gross Profit | 6.84B | 6.71B | 6.52B | 6.35B | 6.20B |
| SG&A Expenses | 3.29B | 3.23B | 3.10B | 2.98B | 2.91B |
| Depreciation & Amortization | 1.08B | 1.10B | 1.08B | 1.08B | 1.08B |
| Other Operating Expenses | 3.00M | 3.00M | 3.00M | 1.00M | 1.00M |
| Total Operating Expenses | 7.77B | 7.70B | 7.48B | 7.29B | 7.15B |
| Operating Income | 1.86B | 1.77B | 1.72B | 1.68B | 1.61B |
| Income Before Tax | 167.00M | -49.00M | -354.00M | -323.00M | -390.00M |
| Income Tax Expenses | 239.00M | 168.00M | 153.00M | 156.00M | 221.00M |
| Earnings from Continuing Operations | -72.00 | -217.00 | -507.00 | -479.00 | -611.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 26.00M | 39.00M | 36.00M | 24.00M | 19.00M |
| Net Income | -46.00M | -178.00M | -471.00M | -455.00M | -592.00M |
| EBIT | 1.86B | 1.77B | 1.72B | 1.68B | 1.61B |
| EBITDA | 3.13B | 3.06B | 2.99B | 2.95B | 2.87B |
| EPS Basic | -0.13 | -0.49 | -1.29 | -1.25 | -1.63 |
| Normalized Basic EPS | 0.84 | 0.71 | 0.62 | 0.55 | 0.50 |
| EPS Diluted | -0.13 | -0.49 | -1.29 | -1.25 | -1.63 |
| Normalized Diluted EPS | 0.84 | 0.71 | 0.62 | 0.55 | 0.50 |
| Average Basic Shares Outstanding | 1.48B | 1.46B | 1.45B | 1.45B | 1.45B |
| Average Diluted Shares Outstanding | 1.48B | 1.46B | 1.46B | 1.45B | 1.45B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
